Malalis, Myla .

HRN: 11-66-32  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/13/2025
METRONIDAZOLE 500MG (TAB)
12/13/2025
12/20/2025
PO
500mg
TID
S/P LTCS
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: